vs
Side-by-side financial comparison of McKesson Corporation (MCK) and Nvidia (NVDA). Click either name above to swap in a different company.
McKesson Corporation is the larger business by last-quarter revenue ($106.2B vs $68.1B, roughly 1.6× Nvidia). Nvidia runs the higher net margin — 63.1% vs 1.1%, a 61.9% gap on every dollar of revenue. On growth, Nvidia posted the faster year-over-year revenue change (73.2% vs 11.4%). Nvidia produced more free cash flow last quarter ($34.9B vs $1.1B). Over the past eight quarters, Nvidia's revenue compounded faster (61.7% CAGR vs 17.9%).
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company.
Nvidia Corporation is an American technology company headquartered in Santa Clara, California. Founded in 1993 by Jensen Huang, Chris Malachowsky, and Curtis Priem, it develops graphics processing units (GPUs), systems on chips (SoCs), and application programming interfaces (APIs) for data science, high-performance computing, video games, and mobile and automotive applications. Nvidia has been described as a Big Tech company.
MCK vs NVDA — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $106.2B | $68.1B |
| Net Profit | $1.2B | $43.0B |
| Gross Margin | 3.5% | 75.0% |
| Operating Margin | 1.5% | 65.0% |
| Net Margin | 1.1% | 63.1% |
| Revenue YoY | 11.4% | 73.2% |
| Net Profit YoY | 34.9% | 94.5% |
| EPS (diluted) | $9.59 | $1.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $68.1B | ||
| Q4 25 | $106.2B | $57.0B | ||
| Q3 25 | $103.2B | $46.7B | ||
| Q2 25 | $97.8B | $44.1B | ||
| Q1 25 | $90.8B | $39.3B | ||
| Q4 24 | $95.3B | $35.1B | ||
| Q3 24 | $93.7B | $30.0B | ||
| Q2 24 | $79.3B | $26.0B |
| Q1 26 | — | $43.0B | ||
| Q4 25 | $1.2B | $31.9B | ||
| Q3 25 | $1.1B | $26.4B | ||
| Q2 25 | $784.0M | $18.8B | ||
| Q1 25 | $1.3B | $22.1B | ||
| Q4 24 | $879.0M | $19.3B | ||
| Q3 24 | $241.0M | $16.6B | ||
| Q2 24 | $915.0M | $14.9B |
| Q1 26 | — | 75.0% | ||
| Q4 25 | 3.5% | 73.4% | ||
| Q3 25 | 3.4% | 72.4% | ||
| Q2 25 | 3.4% | 60.5% | ||
| Q1 25 | 4.0% | 73.0% | ||
| Q4 24 | 3.4% | 74.6% | ||
| Q3 24 | 3.5% | 75.1% | ||
| Q2 24 | 4.0% | 78.4% |
| Q1 26 | — | 65.0% | ||
| Q4 25 | 1.5% | 63.2% | ||
| Q3 25 | 1.4% | 60.8% | ||
| Q2 25 | 1.1% | 49.1% | ||
| Q1 25 | 1.8% | 61.1% | ||
| Q4 24 | 1.3% | 62.3% | ||
| Q3 24 | 0.6% | 62.1% | ||
| Q2 24 | 1.3% | 64.9% |
| Q1 26 | — | 63.1% | ||
| Q4 25 | 1.1% | 56.0% | ||
| Q3 25 | 1.1% | 56.5% | ||
| Q2 25 | 0.8% | 42.6% | ||
| Q1 25 | 1.4% | 56.2% | ||
| Q4 24 | 0.9% | 55.0% | ||
| Q3 24 | 0.3% | 55.3% | ||
| Q2 24 | 1.2% | 57.1% |
| Q1 26 | — | $1.76 | ||
| Q4 25 | $9.59 | $1.30 | ||
| Q3 25 | $8.92 | $1.08 | ||
| Q2 25 | $6.25 | $0.76 | ||
| Q1 25 | $9.90 | $-4.49 | ||
| Q4 24 | $6.95 | $0.78 | ||
| Q3 24 | $1.87 | $0.67 | ||
| Q2 24 | $7.00 | $5.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0B | $10.6B |
| Total DebtLower is stronger | $5.4B | $8.5B |
| Stockholders' EquityBook value | $-1.3B | $157.3B |
| Total Assets | $84.2B | $206.8B |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $10.6B | ||
| Q4 25 | $3.0B | $60.6B | ||
| Q3 25 | $4.0B | $56.8B | ||
| Q2 25 | $2.4B | $53.7B | ||
| Q1 25 | $5.7B | $43.2B | ||
| Q4 24 | $1.1B | $38.5B | ||
| Q3 24 | $2.5B | $34.8B | ||
| Q2 24 | $2.3B | $31.4B |
| Q1 26 | — | $8.5B | ||
| Q4 25 | $5.4B | $8.5B | ||
| Q3 25 | $6.0B | $8.5B | ||
| Q2 25 | $6.5B | $8.5B | ||
| Q1 25 | $4.5B | $8.5B | ||
| Q4 24 | $4.4B | $8.5B | ||
| Q3 24 | $5.7B | $8.5B | ||
| Q2 24 | $5.6B | $9.7B |
| Q1 26 | — | $157.3B | ||
| Q4 25 | $-1.3B | $118.9B | ||
| Q3 25 | $-1.7B | $100.1B | ||
| Q2 25 | $-2.0B | $83.8B | ||
| Q1 25 | $-2.1B | $79.3B | ||
| Q4 24 | $-3.1B | $65.9B | ||
| Q3 24 | $-3.0B | $58.2B | ||
| Q2 24 | $-1.8B | $49.1B |
| Q1 26 | — | $206.8B | ||
| Q4 25 | $84.2B | $161.1B | ||
| Q3 25 | $84.2B | $140.7B | ||
| Q2 25 | $81.3B | $125.3B | ||
| Q1 25 | $75.1B | $111.6B | ||
| Q4 24 | $71.1B | $96.0B | ||
| Q3 24 | $72.4B | $85.2B | ||
| Q2 24 | $71.7B | $77.1B |
| Q1 26 | — | 0.05× | ||
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.2B | $36.2B |
| Free Cash FlowOCF − Capex | $1.1B | $34.9B |
| FCF MarginFCF / Revenue | 1.1% | 51.2% |
| Capex IntensityCapex / Revenue | 0.1% | 1.9% |
| Cash ConversionOCF / Net Profit | 1.04× | 0.84× |
| TTM Free Cash FlowTrailing 4 quarters | $10.0B | $96.7B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $36.2B | ||
| Q4 25 | $1.2B | $23.8B | ||
| Q3 25 | $2.4B | $15.4B | ||
| Q2 25 | $-918.0M | $27.4B | ||
| Q1 25 | $7.7B | $16.6B | ||
| Q4 24 | $-2.4B | $17.6B | ||
| Q3 24 | $2.1B | $14.5B | ||
| Q2 24 | $-1.4B | $15.3B |
| Q1 26 | — | $34.9B | ||
| Q4 25 | $1.1B | $22.1B | ||
| Q3 25 | $2.3B | $13.5B | ||
| Q2 25 | $-1.0B | $26.2B | ||
| Q1 25 | $7.6B | $15.6B | ||
| Q4 24 | $-2.5B | $16.8B | ||
| Q3 24 | $2.0B | $13.5B | ||
| Q2 24 | $-1.5B | $15.0B |
| Q1 26 | — | 51.2% | ||
| Q4 25 | 1.1% | 38.8% | ||
| Q3 25 | 2.2% | 28.8% | ||
| Q2 25 | -1.1% | 59.4% | ||
| Q1 25 | 8.3% | 39.5% | ||
| Q4 24 | -2.6% | 47.9% | ||
| Q3 24 | 2.1% | 45.0% | ||
| Q2 24 | -1.9% | 57.5% |
| Q1 26 | — | 1.9% | ||
| Q4 25 | 0.1% | 2.9% | ||
| Q3 25 | 0.1% | 4.1% | ||
| Q2 25 | 0.1% | 2.8% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.1% | 3.3% | ||
| Q2 24 | 0.1% | 1.4% |
| Q1 26 | — | 0.84× | ||
| Q4 25 | 1.04× | 0.74× | ||
| Q3 25 | 2.18× | 0.58× | ||
| Q2 25 | -1.17× | 1.46× | ||
| Q1 25 | 6.15× | 0.75× | ||
| Q4 24 | -2.71× | 0.91× | ||
| Q3 24 | 8.71× | 0.87× | ||
| Q2 24 | -1.51× | 1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MCK
| North American Pharmaceutical Segment | $88.3B | 83% |
| Oncology And Multispecialty Segment | $13.0B | 12% |
| Medical Surgical Solutions Segment | $3.0B | 3% |
| Prescription Technology Solutions Segment | $1.5B | 1% |
NVDA
| Compute | $51.3B | 75% |
| Networking | $11.0B | 16% |
| Gaming | $3.7B | 5% |
| Professional Visualization | $1.3B | 2% |
| Automotive | $604.0M | 1% |
| OEM And Other | $161.0M | 0% |
| Inventory Purchase Obligations In Excess Of Projections | $31.0M | 0% |
